Unknown

Dataset Information

0

Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction.


ABSTRACT: Bioassay-guided fractionation of two cyanobacterial extracts from Papua New Guinea has yielded hoiamide D in both its carboxylic acid and conjugate base forms. Hoiamide D is a polyketide synthase (PKS)/non-ribosomal peptide synthetase (NRPS)-derived natural product that features two consecutive thiazolines and a thiazole, as well as a modified isoleucine residue. Hoiamide D displayed inhibitory activity against p53/MDM2 interaction (EC(50)=4.5 ?M), an attractive target for anticancer drug development.

SUBMITTER: Malloy KL 

PROVIDER: S-EPMC3248991 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction.

Malloy Karla L KL   Choi Hyukjae H   Fiorilla Catherine C   Valeriote Fred A FA   Matainaho Teatulohi T   Gerwick William H WH  

Bioorganic & medicinal chemistry letters 20111024 1


Bioassay-guided fractionation of two cyanobacterial extracts from Papua New Guinea has yielded hoiamide D in both its carboxylic acid and conjugate base forms. Hoiamide D is a polyketide synthase (PKS)/non-ribosomal peptide synthetase (NRPS)-derived natural product that features two consecutive thiazolines and a thiazole, as well as a modified isoleucine residue. Hoiamide D displayed inhibitory activity against p53/MDM2 interaction (EC(50)=4.5 μM), an attractive target for anticancer drug develo  ...[more]

Similar Datasets

| S-EPMC4798270 | biostudies-literature
| S-EPMC4247201 | biostudies-literature
| S-EPMC2676446 | biostudies-literature
| S-EPMC4838565 | biostudies-literature
| S-EPMC3436289 | biostudies-literature
| S-EPMC3747081 | biostudies-literature
| S-EPMC3057987 | biostudies-literature
| S-EPMC4420247 | biostudies-literature
| S-EPMC7881117 | biostudies-literature
| S-EPMC4104591 | biostudies-literature